Skip to content

S. 4109 · 119th Congress (2025–2027)

Stem Cell Therapeutic and Research Reauthorization Act of 2026

This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA).

The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research. The bill also expands periodic reviews of the state of stem cell science to specifically include a review of the use of high-quality cord blood units and other emergent technologies to develop new therapies for potential inclusion in the program.

Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.

Show official title

A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

Reported

This bill’s path

This is S. 4109’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

Sponsor
Sen. Jack Reed (D-RI)
Cosponsors
3 cosponsors

3 original · 0 later

  1. Sen. James Lankford (R-OK)· Original · Mar 17, 2026
  2. Sen. Tim Scott (R-SC)· Original · Mar 17, 2026
  3. Sen. Tina Smith (D-MN)· Original · Mar 17, 2026
Policy area
Health
Subjects
  • Biological and life sciences
  • Blood and blood diseases
  • Cell biology and embryology
  • Health programs administration and funding
  • Organ and tissue donation and transplantation

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest
    ▸ 3 committee actions · Mar 17, 2026 – Jun 22, 2026
    1. Referred to committee

      Congressional Record S1093; S1093

      Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

      Sources
    2. Ordered reported

      Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

      Sources
    3. Reported by committee

      Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

      Sources

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Mar 17, 2026 · Markup Jun 17, 2026 · Reported Jun 22, 2026
    1. Jun 17, 2026 · Open business meeting

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Reported to Senate
Titles (2)
  1. Stem Cell Therapeutic and Research Reauthorization Act of 2026

    Short title, Display title · Reported to Senate, Introduced in Senate

  2. A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes.

    Official title · Introduced in Senate